OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Functional and Clinical Importance of SGLT2-inhibitors in Frailty: From the Kidney to the Heart
Gaetano Santulli, Fahimeh Varzideh, Imma Forzano, et al.
Hypertension (2023) Vol. 80, Iss. 9, pp. 1800-1809
Open Access | Times Cited: 39
Gaetano Santulli, Fahimeh Varzideh, Imma Forzano, et al.
Hypertension (2023) Vol. 80, Iss. 9, pp. 1800-1809
Open Access | Times Cited: 39
Showing 1-25 of 39 citing articles:
Prediabetes Increases the Risk of Frailty in Prefrail Older Adults With Hypertension: Beneficial Effects of Metformin
Gaetano Santulli, Valeria Visco, Fahimeh Varzideh, et al.
Hypertension (2024) Vol. 81, Iss. 7, pp. 1637-1643
Closed Access | Times Cited: 32
Gaetano Santulli, Valeria Visco, Fahimeh Varzideh, et al.
Hypertension (2024) Vol. 81, Iss. 7, pp. 1637-1643
Closed Access | Times Cited: 32
Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Y J Youn, Seung Yeon Kim, Hyun‐Jeong Jeong, et al.
Frontiers in Neuroendocrinology (2024) Vol. 73, pp. 101131-101131
Open Access | Times Cited: 20
Y J Youn, Seung Yeon Kim, Hyun‐Jeong Jeong, et al.
Frontiers in Neuroendocrinology (2024) Vol. 73, pp. 101131-101131
Open Access | Times Cited: 20
Amyloid-β and heart failure in Alzheimer’s disease: the new vistas
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Hamdoon A. Mohammed, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 3
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Hamdoon A. Mohammed, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 3
SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system
Jiaqi Mei, Yi Li, Liyan Niu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Jiaqi Mei, Yi Li, Liyan Niu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail diabetic elders with chronic kidney disease
Pasquale Mone, Germano Guerra, Angela Lombardi, et al.
Pharmacological Research (2024) Vol. 200, pp. 107055-107055
Open Access | Times Cited: 12
Pasquale Mone, Germano Guerra, Angela Lombardi, et al.
Pharmacological Research (2024) Vol. 200, pp. 107055-107055
Open Access | Times Cited: 12
Role of Uremic Toxins, Oxidative Stress, and Renal Fibrosis in Chronic Kidney Disease
Weronika Frąk, Bartłomiej Dąbek, Marta Balcerczyk-Lis, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 687-687
Open Access | Times Cited: 11
Weronika Frąk, Bartłomiej Dąbek, Marta Balcerczyk-Lis, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 687-687
Open Access | Times Cited: 11
SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells
Camilla Anastasio, Isabella Donisi, Vitale Del Vecchio, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 9
Camilla Anastasio, Isabella Donisi, Vitale Del Vecchio, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 9
SGLT2 Inhibitors in Kidney Diseases—A Narrative Review
Agata Gajewska, Jakub Wasiak, Natalia Sapeda, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4959-4959
Open Access | Times Cited: 8
Agata Gajewska, Jakub Wasiak, Natalia Sapeda, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4959-4959
Open Access | Times Cited: 8
Relationship between changes in the triglyceride glucose-body mass index and frail development trajectory and incidence in middle-aged and elderly individuals: a national cohort study
Kai Guo, Qi Wang, Lin Zhang, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Kai Guo, Qi Wang, Lin Zhang, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
SGLT2 inhibitors and GLP-1 receptor agonists: which is the best anti-frailty drug?
Pasquale Mone, Michele Ciccarelli, Stanislovas S. Jankauskas, et al.
The Lancet Healthy Longevity (2024), pp. 100632-100632
Open Access | Times Cited: 6
Pasquale Mone, Michele Ciccarelli, Stanislovas S. Jankauskas, et al.
The Lancet Healthy Longevity (2024), pp. 100632-100632
Open Access | Times Cited: 6
Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis
Jui‐Yi Chen, Heng‐Chih Pan, Chih‐Chung Shiao, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Jui‐Yi Chen, Heng‐Chih Pan, Chih‐Chung Shiao, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Editorial: Frailty and oxidative stress
Pasquale Mone, Antonio De Luca, Gaetano Santulli
Frontiers in Aging (2024) Vol. 4
Open Access | Times Cited: 4
Pasquale Mone, Antonio De Luca, Gaetano Santulli
Frontiers in Aging (2024) Vol. 4
Open Access | Times Cited: 4
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access
Association Between Frailty and Subjective Life Expectancy in Sub-Saharan Africa: Evidence from Cote D'Ivoire
Gideon Dzando, Richard K. Moussa
Archives of Gerontology and Geriatrics (2025) Vol. 131, pp. 105757-105757
Closed Access
Gideon Dzando, Richard K. Moussa
Archives of Gerontology and Geriatrics (2025) Vol. 131, pp. 105757-105757
Closed Access
Comparative Effectiveness of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Preventing Alzheimer's Disease, Vascular Dementia, and Other Dementia Types Among Patients with Type 2 Diabetes
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes & Metabolism (2025), pp. 101623-101623
Closed Access
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes & Metabolism (2025), pp. 101623-101623
Closed Access
Effect of sodium-glucose co-transporter 2 inhibitor on contrast-induced acute kidney injury and prognosis in type 2 diabetes patients undergoing percutaneous coronary intervention
Shicheng Yang, Huifang Hao, Xiangwei Zhai, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Shicheng Yang, Huifang Hao, Xiangwei Zhai, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Frailty incidence by diabetes treatment regimens in older adults with diabetes mellitus in the ASPirin in Reducing Events in the Elderly Study
Sara Espinoza, Jonathan Broder, Rory Wolfe, et al.
GeroScience (2025)
Open Access
Sara Espinoza, Jonathan Broder, Rory Wolfe, et al.
GeroScience (2025)
Open Access
Examination of Physical Fitness and Nutritional Status in Geriatric Individuals with and without Type 2 Diabetes Mellitus
Özge Cemali, Mustafa Cemali, Özgün Elmas, et al.
Physical & Occupational Therapy In Geriatrics (2025), pp. 1-18
Closed Access
Özge Cemali, Mustafa Cemali, Özgün Elmas, et al.
Physical & Occupational Therapy In Geriatrics (2025), pp. 1-18
Closed Access
SGLT2 inhibitors: an evidence-based update on cardiovascular implications
Imma Forzano, Scott Wilson, Angela Lombardi, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 9, pp. 839-847
Closed Access | Times Cited: 10
Imma Forzano, Scott Wilson, Angela Lombardi, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 9, pp. 839-847
Closed Access | Times Cited: 10
Risks and Benefits of SGLT-2 Inhibitors for Type 1 Diabetes Patients Using Automated Insulin Delivery Systems—A Literature Review
Viviana Elian, Violeta Popovici, Oana Karampelas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 1972-1972
Open Access | Times Cited: 3
Viviana Elian, Violeta Popovici, Oana Karampelas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 1972-1972
Open Access | Times Cited: 3
Hypertension in frail older adults: current perspectives
Liying Li, Linjia Duan, Ying Xu, et al.
PeerJ (2024) Vol. 12, pp. e17760-e17760
Open Access | Times Cited: 3
Liying Li, Linjia Duan, Ying Xu, et al.
PeerJ (2024) Vol. 12, pp. e17760-e17760
Open Access | Times Cited: 3
Renoprotective potential of concomittant medications with SGLT2 inhibitors and renin-angiotensin system inhibitors in diabetic nephropathy without albuminuria: a retrospective cohort study
Tatsuya Ishibashi, Shuhei Morita, Hiroto Furuta, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Tatsuya Ishibashi, Shuhei Morita, Hiroto Furuta, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Dapagliflozin versus empagliflozin in patients with chronic kidney disease
Hilmi Alnsasra, Gal Tsaban, Adam Solomon, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Hilmi Alnsasra, Gal Tsaban, Adam Solomon, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
A cost-effectiveness analysis of empagliflozin for heart failure patients across the full spectrum of ejection fraction in Spain: combined results of the EMPEROR-Preserved and EMPEROR-Reduced trials
Xavier García–Moll, Francesco Croci, Alexandra Solé, et al.
Expert Review of Cardiovascular Therapy (2024) Vol. 22, Iss. 1-3, pp. 131-139
Open Access | Times Cited: 2
Xavier García–Moll, Francesco Croci, Alexandra Solé, et al.
Expert Review of Cardiovascular Therapy (2024) Vol. 22, Iss. 1-3, pp. 131-139
Open Access | Times Cited: 2
Safety assessment of dapagliflozin: Real-world adverse event analysis based on the FAERS database from 2012 to 2023
Zhengxi Zhou, Xiaotian Yao
Heliyon (2024) Vol. 10, Iss. 12, pp. e33306-e33306
Open Access | Times Cited: 2
Zhengxi Zhou, Xiaotian Yao
Heliyon (2024) Vol. 10, Iss. 12, pp. e33306-e33306
Open Access | Times Cited: 2
